Guardant Health (GH) Cash from Financing Activities (2017 - 2026)

Guardant Health has disclosed Cash from Financing Activities across 10 years of filings, most recently posting -$21.6 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$21.6 million, up 67.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $716.4 million (up 1172.91% YoY), and the FY2025 annual result was $671.1 million, up 67482.83% from the prior year.
• Cash from Financing Activities came in at -$21.6 million for Q1 2026 at Guardant Health, down from $732.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $732.0 million in Q4 2025 to a low of -$172.1 million in Q2 2022.
• The 5-year median for Cash from Financing Activities is -$12000.0 (2022), against an average of $55.1 million.
• Across the five-year window, Cash from Financing Activities plunged 7016.67% in 2023 and surged 25041.33% in 2025, its largest moves.
• Guardant Health's Cash from Financing Activities stood at $2.3 million in 2022, then jumped by 3807.16% to $90.6 million in 2023, then slumped by 103.24% to -$2.9 million in 2024, then soared by 25041.33% to $732.0 million in 2025, then tumbled by 102.95% to -$21.6 million in 2026.
• The last three Cash from Financing Activities figures came in at -$21.6 million (Q1 2026), $732.0 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.